Author:
Erem C.,Ersoz H. Ö.,Karti S. S.,Ukinç K.,Hacihasanoglu A.,Değer O.,Telatar M.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference30 articles.
1. Presti C.F., Hart R.G. Thyrotoxicosis, atrial fibrillation and embolism, revisited. Am. Heart J. 1989, 117: 976–977.
2. Bar-Sela S., Ehrenfeld M., Eliakim M. Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch. Intern. Med. 1981, 141: 1191–1192.
3. Li Y., Chen H., Tan J., Wang X., Liang H., Sun X. Impaired release of tissue plasminogen activator from the endothelium in Graves’ disease — indicator of endothelial dysfunction and reduced fibrinolytic capacity. Eur. J. Clin. Invest. 1998, 28: 1050–1054.
4. Loeliger E.A., Esch vd B. The biological disappearance rate of prothrombin, factors VII, IX and X from plasma in hypothyroidism, hyperthyroidism, and during fever. Thromb. Diathes. Haemorrh. 1963, 10: 267–277.
5. Kellett H.A., Sawers J.S.A., Boulton F.E., Cholerton S., Park B.K., Toft A.D. Problems of anticoagulation with warfarin in hyperthyroidism. Q. J. M. 1986, 58: 43–51.
Cited by
119 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献